−£10.59m
vs Dec 2023Active09430782Private limited companyLondon
IOX THERAPEUTICS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Iox Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Iox Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
IOX THERAPEUTICS LIMITED is an active private limited company (company number 09430782) incorporated on 10 February 2015, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£10.59m and cash of £45k, with 5 employees on average. Net assets fell 7% on the prior period (−£9.91m).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- Salvarx Limited
- owns 50–75% of shares
- holds 50–75% of voting rights
- Portage Biotech Inc
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 10 February 201511 yrs ago
- Next accounts due
- 30 September 202627 days overdue
- Confirmation statement due
- 24 February 2027in 120 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£45k
−84%vs Dec 2023Not reported
5
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£10.59m | £45k | — | £10.72m | — | — | 5 |
| 31 December 2023 | −£9.91m | £286k | — | £11.58m | — | — | 5 |
Current ratio0.01Current assets ÷ creditors within one year
Cash per employee£9,034Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-10,590,680 at 31 December 2024
- Current assets below creditors within one yearCurrent ratio 0.01
- Incorporated five or more years agoIncorporated 10 February 2015
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 120 days
- Next accounts due27 days overdue
- Accounts period endNet liabilities £10.59m · small accounts
- Accounts period endNet liabilities £9.91m · small accounts
- Incorporated
08
Similar companies in London
- CYBIN UK LTDLondon · inc. Feb 2015
- DARK HORSE CONSULTING EUROPE LIMITEDLondon · inc. Feb 2015
- NEXT CLINICAL RESEARCH ORGANISATION LIMITEDLondon · inc. Feb 2015
- NATRULE LIMITEDLondon · inc. Jan 2015
- SEE-THROUGH SCIENTIFIC LIMITEDLondon · inc. Jan 2015
- WHEATLEY RESEARCH LIMITEDLondon · inc. Jan 2015
All companies incorporated on 10 February 2015 · in Feb 2015.
09
Reminders for IOX THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.